Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid integrity through activation of NF-κB

Journal of Virology

Volumn 77, Issue 7, 2003, Pages 4033-4042

  Biermer, Michael ^a,b   Puro, Robyn ^a   Schneider, Robert J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ARTICLE; CELL KILLING; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA REPLICATION; GENE OVEREXPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CANCER; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS CAPSID; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; CAPSID; CELL LINE; DNA REPLICATION; DNA, VIRAL; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; INTERFERONS; NF-KAPPA B; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0037379219     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.7.4033-4042.2003     Document Type: Article

References (67)

1. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170.
2. Benn, J., and R. J. Schneider. 1994, Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signalling cascade. Proc. Natl. Acad. Sci. USA 91:10350-10354,
3. Benn, J., F. Su, M. Doria, and R. J. Schneider. 1996. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J. Virol. 70:4978-4985.
4. Bergametti, F., S. Prigent, B. Luber, A. Benoit, P. Tiollais, A. Sarasin, and C. Transy. 1999. The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines. Oncogene 18:2860-2871.
5. 1 transit via a Src kinase pathway. J. Virol. 75:4247-4257.
6. Bouchard, M. J., L. H. Wang, and R. J. Schneider. 2001. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294:2376-2378.
7. Cavanaugh, V. J., L. G. Guidotti, and F. V. Chisari. 1998. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. J. Virol. 72:2630-2637.
8. Cavanaugh, V. J., L. G. Guidotti, and F. V. Chisari. 1997. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J. Virol. 71:3236-3243.
9. Chen, H.-S., S. Kaneko, R. Girones, R. W. Anderson, W. E. Hornbuckle, B. C. Tennant, P. J. Cote, J. L. Gerin, R. H. Purcell, and R. H. Miller. 1993. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 67:1218-1226.
10. Chirillo, P., M. Falco, P. L. Puri, M. Artini, C. Balsano, M. Levrero, and G. Natoli. 1996. Hepatitis B virus pX activates NF-κB-dependent transcription through a Raf-independent pathway. J. Virol. 70:641-646.
11. Chirillo, P., S. Pagano, G. Natoli, P. L. Puri, V. L. Burgio, C. Balsano, and M. Levrero. 1997. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc. Natl. Acad. Sci. USA 94:8162-8167.
12. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-554.
13. Ganem, D., and R. J. Schneider. 2001. The molecular biology of the hepatitis B viruses, p. 2923-2970. In D. Knipe and P. Howley (ed.), Field's virology, 4th ed., vol. 2. Lippincott, New York, N.Y.
14. Gilles, P. N., G. Fey, and F. V. Chisari. 1992. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66:3955-3960.
15. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65-91.
16. Guidotti, L. G., S. Guilhot, and F. V. Chisari. 1994. Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J. Virol. 68:1265-1270.
17. Guidotti, L. G., T. Ishikawa, M. V. Hobbs., B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
18. Guidotti, L. G., B. Matzke, H. Schaller, and F. V. Chisari. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
19. Guidotti, L. G., H. McClary, J. M. Loudis, and F. V. Chisari. 2000. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J. Exp. Med. 191:1247-1252.
20. Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
21. Guo, J. T., H. Zhou, C. Liu, C. Aldrich, J. Saputelli, T. Whitaker, M. I. Barrasa, W. S. Mason, and C. Seeger. 2000. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J. Virol. 74:1495-1505.
22. Hagelstein, J., A. Kist, W. Stremmel, and P. R. Galle. 1998. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells. Arzneim.-Forsch. 48:343-347.
23. Herbein, G., and W. A. O'Brien. 2000. Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proc. Soc. Exp. Biol. Med. 223:241-257.
24. Honda, A., O. Yokosuka, K. Suzuki, and H. Saisho. 2000. Detection of mutations in hepatitis B virus enhancer 2/core promoter and X protein regions in patients with fatal hepatitis B virus infection. J. Med. Virol. 62:167-176.
25. Hudziak, R. M., G. D. Lewis, W. E. Holmes, A. Ullrich, and H. M. Shepard. 1990. Selection for transformation and met protooncogene amplification in NIH 3T3 fibroblasts using tumor necrosis factor alpha. Cell Growth Differ. 1:129-134.
26. Kajino, K., A. R. Jilbert, J. Saputelli, C. E. Aldrich, J. Cullen, and W. Mason. 1994. Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J. Virol. 68:5792-5803.
27. Kann, M., B. Sodeik, A. Vlachou, W. H. Gerlich, and A. Helenius. 1999. Phosphorylation-dependent binding of hepatitis B virus core particles to the nuclear pore complex. J. Cell Biol. 145:45-55.
28. Karin, M., and M. Delhase. 2000. The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling. Semin. Immunol. 12:85-98.
29. Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3:221-227.
30. Kladney, R. D., X. Cui, G. A. Bulla, E. M. Brunt, and C. J. Fimmel. 2002. Expression of GP73, a resident Golgi membrane protein, in viral and non-viral liver disease. Hepatology 35:1431-1440.
31. Klein, N., M. Bouchard, L.-H. Wang, C. Kobarg, and R. J. Schneider. 1999. Src kinases involved in hepatitis B virus replication. EMBO J. 18:5019-5027.
32. Lara-Pezzi, E., P. L. Majano, M. Gomez-Gonzalo, C. Garcia-Monzon, R. Moreno-Otero, M. Leverero, and M. Lopez-Cabrera. 1998. The hepatitis B virus X protein up-regulates tumor necrosis factor-α gene expression in hepatocytes. Hepatology 28:1013-1021.
33. Lavon, I., I. Goldberg, S. Amit, L. Landsman, S. Jung, B. Z. Tsuberi, I. Barsback, J. Kopolovic, E. Galun, H. Bujard, and Y. Ben-Neriah. 2000. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation. Nat. Med. 6:573-577.
34. Levrero, M., C. Balsano, G. Natoli, M. L. Avantaggiati, and E. Elfassi. 1990. Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2. J. Virol. 64:3082-3086.
35. Lucito, R., and R. J. Schneider. 1992. Hepatitis B virus X protein activates transcription factor NF-κB without a requirement for protein kinase C. J. Virol. 66:983-991.
36. Mahe, Y., N. Mukaida, K. Kuno, M. Akiyama, N. Ikeda, K. Matshushima, and S. Murakami. 1991. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor κB and CCAAT/enhancer-binding protein-like cis elements. J. Biol. Chem. 266:13759-13763.
37. McClary, H., R. Koch, F. V. Chisari, and L. G. Guidotti. 2000. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 74:2255-2264.
38. Melegari, M., P. P. Scaglioni, and J. R. Wands. 1998. Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J. Virol. 72:1737-1743.
39. Natoli, G., M. L. Avantaggiati, P. Chirillo, P. L. Puri, A. Ianni, C. Balsano, and M. Levrero. 1994. Ras- and raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 9:2837-2843.
40. Pasquetto, V., S. F. Wieland, S. L. Uprichard, M. Tripodi, and F. V. Chisari. 2002. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J. Virol. 76:5646-5653.
41. Pugh, J. C., K. Yaginuma, K. Koike, and J. Summers. 1988. Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro. J. Virol. 62:3513-3516.
42. Rang, A., S. Gunther, and H. Will. 1999. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells. J. Hepatol. 31:791-799.
43. Rang, A., T. Heise, and H. Will. 2001. Lack of a role of the interferonstimulated response element-like region in interferon alpha-induced suppression of hepatitis B virus in vitro. J. Biol. Chem. 276:3531-3535.
44. Ren, S., and M. Nassal. 2001. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. J. Virol. 75:1104-1116.
45. Romero, R., and J. E. Lavine. 1996. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 23:17-23.
46. Scaglioni, P. P., M. Melegari, and J. R. Wands. 1997. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 233:374-381.
47. Scaglioni, P. P., M. Melegari, and J. R. Wands. 1997. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J. Virol. 71:345-353.
48. Schultz, U., and F. V. Chisari. 1999. Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J. Virol. 73:3162-3168.
49. Schultz, U., J. Summers, P. Staeheli, and F. V. Chisari. 1999. Elimination of duck hepatitis B virus RNA-containing capsids in duck alpha interferontreated hepatocytes. J. Virol. 73:5459-5465.
50. Schuster, R., W. H. Gerlich, and S. Schaefer. 2000. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene 19:1173-1180.
51. Semenkova, L. N., E. I. Dudich, I. V. Dudich, L. N. Shingarova, and V. G. Korobko. 1997. Alpha-fetoprotein as a TNF resistance factor for the human hepatocarcinoma cell line HepG2. Tumour Biol. 18:30-40.
52. Shimizu, Y., L G. Guidotti, P. Fowler, and F. V. Chisari. 1998. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J. Immunol. 161:4520-4529.
53. Sirma, H., C. Giannini, K. Poussin, P. Paterlini, D. Kremsdorf, and C. Brechot. 1999. Hepatitis B virus X mutants present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 18:4848-4859.
54. Su, F., and R. J. Schneider. 1996. Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J. Virol. 70:4558-4566.
55. Su, F., and R. J. Schneider. 1997. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by TNFα. Proc. Natl. Acad. Sci. USA 94:8744-8749.
56. Su, F., C. N. Theodosis, and R. J. Schneider. 2001. Role of NF-κB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J. Virol. 75:215-225.
57. Terradillos, O., O. Billet, C.-A. Rnard, R. Levy, T. Molina, P. Briand, and M. A. Buendia. 1997. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 14:395-404.
58. Terradillos, O., T. Pollicino, H. Lecoeur, M. Tripodi, M. L. Gougeon, P. Tiollais, and M. A. Buendia. 1998. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17:2115-2123.
59. Uchida, T., T. Saitoh, and H. Shinzawa, 1997. Mutations in the X region of hepatitis B virus and their clinical implications. Pathol. Int. 47:183-193.
60. Wang, C.-Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF-α and cancer therapy-induced apoptosis: potentiation by inhibition of NFκB. Science 274:784-787.
61. Wieland, S. F., L. G. Guidotti, and F. V. Chisari. 2000. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J. Virol. 74:4165-4173.
62. Xu, Z., T. S. Yen, L. Wu, C. R. Madden, W. Tan, B. L. Slagle, and J. H. Ou. 2002. Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J. Virol. 76:2579-2584.
63. Yuasa, R., K. Takahashi, B. V. Dien, N. H. Binh, T. Morishita, K. Sato, N. Yamamoto, S. Isomura, K. Yoshioka, T. Ishikawa, S. Mishiro, and S. Kakumu. 2000. Properties of hepatitis B virus genome recovered from Vietnamese patients with fulminant hepatitis in comparison with those of acute hepatitis. J. Med. Virol. 61:23-28.
64. Zamanian-Daryoush, M., T. H. Mogensen, J. A. DiDonato, B. R. Williams. 2000. NF-κB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase. Mol. Cell. Biol. 20:1278-1290.
65. Zandi, E., D. M. Rothwarf, M. Delhase, M. Hayakawa, and M. Karin. 1997. The IκB kinase complex (IKK) contains two kinase subunits. IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91:243-252.
66. Zhou, T., J. T. Guo, F. A. Nunes, K. L. Molnar-Kimber, J. M. Wilson, C. E. Aldrich, J. Saputelli, S. Litwin, L. D. Condreay, C. Seeger, and W. S. Mason. 2000. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections. J. Virol. 74:11754-11763.
67. Zoulim, F., J. Saputelli, and C. Seeger. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68:2026-2030.